SCHEMBL27093626

SCHEMBL27093626

C[C@H]1CCCCN1c1ccc([N+](=O)[O-])cn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.61
▸ ALDH1A1 P00352 3/20 0.59
▸ LMNA P02545 1/20 0.59
▸ ALOX12 P18054 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ HPGD P15428 1/20 0.50
▸ NPC1 O15118 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ ATM Q13315 1/20 0.48
▸ SGPL1 O95470 1/20 0.48
▸ MAPK1 P28482 1/20 0.46
▸ ACHE P22303 1/20 0.44
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29739580 1.00 MAPT (0.61) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL26633342 0.96 MAPT (0.63) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL26633289 0.96 MAPT (0.63) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL26633283 0.96 MAPT (0.63) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL10898231 0.80 MAPT (0.58) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL15141694 0.79 ALDH1A1 (0.61) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL30206059 0.79 ALDH1A1 (0.61) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL15141990 0.79 ALDH1A1 (0.61) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL15141692 0.79 ALDH1A1 (0.61) MAPTALDH1A1LMNAALOX12NPSR1
SCHEMBL2681979 0.79 MAPT (0.55) MAPTALDH1A1LMNAALOX12NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4323350-A1 ISOINDOLINONE COMPOUNDS Monte Rosa Therapeutics AG (CH) 2024-02-21 — — EP disclosed
Send feedback